Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice. 2016

Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
Hematology Research, Biogen, 115 Broadway, Cambridge, MA 02142, United States. Electronic address: sriram.krishnamoorthy@biogen.com.

Anti-factor VIII (FVIII) antibodies is a major complication of FVIII replacement therapy for hemophilia A. We investigated the immune response to recombinant human factor VIII Fc (rFVIIIFc) in comparison to BDD-rFVIII and full-length rFVIII (FL-rFVIII) in hemophilia A mice. Repeated administration of therapeutically relevant doses of rFVIIIFc in these mice resulted in significantly lower antibody responses to rFVIII compared to BDD-rFVIII and FL-rFVIII and reduced antibody production upon subsequent challenge with high doses of rFVIIIFc. The induction of a tolerogenic response by rFVIIIFc was associated with higher percentage of regulatory T-cells, a lower percentage of pro-inflammatory splenic T-cells, and up-regulation of tolerogenic cytokines and markers. Disruption of Fc interactions with either FcRn or Fcγ receptors diminished tolerance induction, suggesting the involvement of these pathways. These results indicate that rFVIIIFc reduces immunogenicity and imparts tolerance to rFVIII demonstrating that recombinant therapeutic proteins may be modified to influence immunogenicity and facilitate tolerance.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic

Related Publications

Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
November 2020, Thrombosis research,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
March 2012, Blood,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
December 2021, Drugs - real world outcomes,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
July 2016, Thrombosis and haemostasis,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
January 2016, Haemophilia : the official journal of the World Federation of Hemophilia,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
January 2014, Blood,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
March 2012, Blood,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
April 2019, International journal of laboratory hematology,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
May 2016, Pediatric blood & cancer,
Sriram Krishnamoorthy, and Tongyao Liu, and Douglas Drager, and Susannah Patarroyo-White, and Ekta Seth Chhabra, and Robert Peters, and Neil Josephson, and David Lillicrap, and Richard S Blumberg, and Glenn F Pierce, and Haiyan Jiang
March 2020, PharmacoEconomics - open,
Copied contents to your clipboard!